Teva Pharmaceutical Industries Limited (TEVA) Announces Appointment of Dr. Arie Belldegrun to Board of Directors

 

Teva Pharmaceutical Industries Limited (TEVA) Announces Appointment of Dr. Arie Belldegrun to Board of Directors

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that Dr. Arie Belldegrun was appointed by the Board of Directors of Teva, at its meeting of February 5, 2013, to fill a vacancy on the Board effective immediately. Dr. Belldegrun's term of office will extend until Teva's 2013 Annual Meeting of Shareholders.

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.